CXCL12/CXCR4-axis dysfunctions: Markers of the rare immunodeficiency disorder WHIM syndrome

Disease Markers

Volumn 29, Issue 3-4, 2010, Pages 189-198

  Bachelerie, Françoise ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; F ACTIN; MITOGEN ACTIVATED PROTEIN KINASE; SERINE; THREONINE;

ALPHA HELIX; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; B LYMPHOCYTE; BACTERIAL INFECTION; BONE MARROW; CARCINOMA; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; LEUKOCYTE; LYMPHOCYTOPENIA; MYELOKATHEXIS; NEUTROPENIA; NEUTROPHIL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PAPILLOMAVIRUS INFECTION; PHOSPHORYLATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECURRENT INFECTION; T LYMPHOCYTE; VERRUCA VULGARIS;

BACTERIA (MICROORGANISMS); HUMAN PAPILLOMAVIRUS;

EID: 78650650415     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/475104     Document Type: Article

References (112)

1. A. Zlotnik, O. Yoshie and H. Nomiyama, The chemokine and chemokine receptor superfamilies and their molecular evolution, Genome Biol 7 (2006), 243.
2. A. Zlotnik and O. Yoshie, Chemokines: a new classification system and their role in immunity, Immunity 12 (2000), 121-127.
3. T. Nagasawa, H. Kikutani and T. Kishimoto, Molecular cloning and structure of a preBcell growthstimulating factor, Proc Natl Acad Sci U S A (1994) 91, 2305-2309.
4. Y. Feng, C.C. Broder, P.E. Kennedy and E.A. Berger, HIV1 entry cofactor: functional cDNA cloning of a seventransmembrane, G proteincoupled receptor, Science (1996) 272, 872-877. (Pubitemid 26154590)
5. Y.R. Zou, A.H. Kottmann, M. Kuroda, I. Taniuchi and D.R. Littman, Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development, Nature (1998) 393, 595-599.
6. T. Nagasawa, S. Hirota, K. Tachibana, N. Takakura, S. Nishikawa, Y. Kitamura et al., Defects of Bcell lymphopoiesis and bonemarrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF1, Nature 382 (1996), 635-638.
7. Q. Ma, D. Jones, P.R. Borghesani, R.A. Segal, T. Nagasawa, T. Kishimoto et al., Impaired Blymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4and SDF1deficient mice, Proc Natl Acad Sci U S A 95 (1998), 9448-9453.
8. C. Martin, P.C. Burdon, G. Bridger, J.C. GutierrezRamos, T.J. Williams and S.M. Rankin, Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence, Immunity (2003) 19, 583-593.
9. C.L. Semerad, F. Liu, A.D. Gregory, K. Stumpf and D.C. Link, GCSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood, Immunity 17 (2002), 413-423.
10. W.C. Liles, H.E. Broxmeyer, E. Rodger, B.Wood, K. Hubel, S. Cooper et al., Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist, Blood 102 (2003), 2728-2730.
11. H.E. Broxmeyer, C.M. Orschell, D.W. Clapp, G. Hangoc, S. Cooper, P.A. Plett et al., Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist, J Exp Med 201 (2005), 1307-1318.
12. C.C. Bleul, J.L. Schultze and T.A. Springer, B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement, J Exp Med 187 (1998), 753-762.
13. A. Corcione, L. Ottonello, G. Tortolina, P. Facchetti, I. Airoldi, R. Guglielmino et al., Stromal cellderived factor1 as a chemoattractant for follicular center lymphoma B cells, J Natl Cancer Inst 92 (2000), 628-635.
14. C.H. Kim and H.E. Broxmeyer, SLC/exodus2/6Ckine/TCA4 induces chemotaxis of hematopoietic progenitor cells: differential activity of ligands of CCR7, CXCR3, or CXCR4 in chemotaxis vs. suppression of progenitor proliferation, J Leukoc Biol 66 (1999), 455-461.
15. C.C. Bleul, M. Farzan, H. Choe, C. Parolin, I. ClarkLewis, J. Sodroski et al., The lymphocyte chemoattractant SDF1 is a ligand for LESTR/fusin and blocks HIV1 entry, Nature 382 (1996), 829-833.
16. E. Oberlin, A. Amara, F. Bachelerie, C. Bessia, J.L. Virelizier, F. ArenzanaSeisdedos et al., The CXC chemokine SDF1 is the ligand for LESTR/fusin and prevents infection by Tcelllineadapted HIV1, Nature 382 (1996), 833-835.
17. A. Muller, B. Homey, H. Soto, N. Ge, D. Catron, M.E. Buchanan et al., Involvement of chemokine receptors in breast cancer metastasis, Nature 410 (2001), 50-56.
18. P.A. Hernandez, R.J. Gorlin, J.N. Lukens, S. Taniuchi, J. Bohinjec, F. Francois et al., Mutations in the chemokine receptor gene CXCR4 are associated withWHIMsyndrome, a combined immunodeficiency disease, Nat Genet 34 (2003), 70-74.
19. W.W. Zuelzer, Myelokathexis - a New Form of Chronic Granulocytopenia. Report of a Case, N Engl J Med 270 (1964), 699-704.
20. M.Wetzler, M. Talpaz, E.S. Kleinerman, A. King, Y.O. Huh, J.U. Gutterman et al., A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia, Am J Med 89 (1990), 663-672.
21. T. Kawai and H.L. Malech, WHIM syndrome: congenital immune deficiency disease, Curr Opin Hematol 16 (2009), 20-26.
22. G.A. Diaz and A.V. Gulino, WHIM syndrome: a defect in CXCR4 signaling, Curr Allergy Asthma Rep 5 (2005), 350-355.
23. K. Balabanian, B. Lagane, J.L. Pablos, L. Laurent, T. Planchenault, O. Verola et al.,WHIMsyndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12, Blood 105 (2005), 2449-2457.
24. J.B. Hagan and P.L. Nguyen, WHIM syndrome, Mayo Clin Proc 82 (2007), 1031.
25. D. Sanmun, D. Garwicz, C.I. Smith, J. Palmblad and B. Fadeel, Stromalderived factor1 abolishes constitutive apop tosis ofWHIMsyndrome neutrophils harbouring a truncating CXCR4 mutation, Br J Haematol 134 (2006), 640-644.
26. M.D. Tarzi, M. Jenner, K. Hattotuwa, A.Z. Faruqi, G.A. Diaz and H.J. Longhurst, Sporadic case of warts, hypogammaglobulinemia, immunodeficiency, andmyelokathexis syndrome, J Allergy Clin Immunol 116 (2005), 1101-1105.
27. B. Weston, R.A. Axtell, E.F. Todd, 3rd., M. Vincent, K.J. Balazovich, S.J. Suchard et al., Clinical and biologic effects of granulocyte colony stimulating factor in the treatment of myelokathexis, J Pediatr 118 (1991), 229-234.
28. M. Wetzler, M. Talpaz, M.J. Kellagher, J.U. Gutterman and R. Kurzrock, Myelokathexis: normalization of neutrophil counts and morphology by GMCSF, JAMA 267 (1992), 2179-2180.
29. J. Bohinjec and D. Andoljsek, Neutrophilreleaing activity of recombinant human granulocytemacrophage colony stimulating factor in myelokathexis, Br J Haematol 82 (1992), 169-170.
30. A.V. Gulino, WHIM syndrome: a genetic disorder of leukcyte trafficking, Curr Opin Allergy Clin Immunol 3 (2003), 443-450.
31. G.A. Diaz, CXCR4 mutations in WHIM syndrome: a misguided immune system? Immunol Rev 203 (2005), 235-243.
32. L.D. Notarangelo and R. Badolato, Leukocyte trafficking in primary immunodeficiencies, J Leukoc Biol 85 (2009), 335-343.
33. K. Palczewski, G proteincoupled receptor rhodopsin, Ann Rev Biochem 75 (2006), 743-767.
34. M.J. SerranoVega, F. Magnani, Y. Shibata and C.G. Tate, Conformational thermostabilization of the beta1adrenergic receptor in a detergentresistant form, Proc Natl Acad Sci U S A 105 (2008), 877-882.
35. S.G. Rasmussen, H.J. Choi, D.M. Rosenbaum, T.S. Kobilka, F.S. Thian, P.C. Edwards et al., Crystal structure of the human beta2 adrenergic Gproteincoupled receptor, Nature 450 (2007), 383-387.
36. M.P. Crump, J.H. Gong, P. Loetscher, K. Rajarathnam, A. Amara, F. ArenzanaSeisdedos et al., Solution structure and basis for functional activity of stromal cellderived factor1; dissociation of CXCR4 activation from binding and inhibition of HIV1, Embo J 16 (1997), 6996-7007.
37. E.K. Gozansky, J.M. Louis, M. Caffrey and G.M. Clore, Mapping the binding of the Nterminal extracellular tail of the CXCR4 receptor to stromal cellderived factor1alpha, J Mol Biol 345 (2005), 651-658.
38. Y. Ohnishi, T. Senda, N. Nandhagopal, K. Sugimoto, T. Shioda, Y. Nagal et al., Crystal structure of recombinant native SDF1alpha with additional mutagenesis studies: an attempt at a more comprehensive interpretation of accumulated structureactivity relationship data, J Interferon Cytokine Res 20 (2000), 691-700.
39. J.W.Murphy, Y. Cho, A. Sachpatzidis, C. Fan,M.E.Hodsdon and E. Lolis, Structural and functional basis of CXCL12 (stromal cellderived factor1 alpha) binding to heparin, J Biol Chem 282 (2007), 10018-10027.
40. A. Brelot, N. Heveker, M. Montes and M. Alizon, Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities, J Biol Chem 275 (2000), 23736-23744.
41. N. Zhou, Z. Luo, J. Luo, D. Liu, J.W. Hall, R.J. Pomerantz et al., Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV1 coreceptor by mutagenesis and molecular modeling studies, J Biol Chem 276 (2001), 42826-42833.
42. B.J. Doranz, S.S. Baik and R.W. Doms, Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events, J Virol 73 (1999), 10346-10358.
43. C.T. Veldkamp, C. Seibert, F.C. Peterson, N.B. De la Cruz, J.C. Haugner, 3rd., H. Basnet et al., Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF1/ CXCL12, Sci Signal 1 (2008), ra4.
44. D. Schols, J.A. Este,G.Henson and E.DeClercq, Bicyclams, a class of potent antiHIV agents, are targeted at the HIV coreceptor fusin/CXCR4, Antiviral Res 35 (1997), 147-156.
45. L.O. Gerlach, R.T. Skerlj, G.J. Bridger and T.W. Schwartz, Molecular interactions of cyclam and bicyclam nonpeptide antagonists with the CXCR4 chemokine receptor, J Biol Chem 276 (2001), 14153-14160.
46. Y. Kofuku, C. Yoshiura, T. Ueda, H. Terasawa, T. Hirai, S. Tominaga et al., Structural basis of the interaction between chemokine stromal cellderived factor1/ CXCL12 and its Gproteincoupled receptor CXCR4, J Biol Chem 284 (2009), 35240-35250.
47. K. Defea, Betaarrestins and heterotrimeric Gproteins: collaborators and competitors in signal transduction, Br J Pharmacol 153(Suppl 1) (2008), S298-S309.
48. A.G. Gilman, G proteins: transducers of receptorgeneratedsignals, Annu Rev Biochem 56 (1987), 615-649.
49. Y. Sotsios, G.C. Whittaker, J. Westwick and S.G. Ward, The CXC chemokine stromal cellderived factor activates a Gicoupled phosphoinositide 3kinase in T lymphocytes, J Immunol 163 (1999), 5954-5963.
50. S. Ortolano, I.Y. Hwang, S.B. Han and J.H. Kehrl, Roles for phosphoinositide 3kinases, Brutons tyrosine kinase, and Jun kinases in B lymphocyte chemotaxis and homing, Eur J Immunol 36 (2006), 1285-1295.
51. M. Thelen, Dancing to the tune of chemokines, Nat Immunol 2 (2001), 129-134.
52. W. Tan, D. Martin and J.S. Gutkind, The Galpha13Rho signaling axis is required for SDF1induced migration through CXCR4, J Biol Chem 281 (2006), 39542-39549.
53. G. Shi, S. PartidaSanchez, R.S. Misra, M. Tighe, M.T. Borchers, J.J. Lee et al., Identification of an alternative G{alpha}qdependent chemokine receptor signal transduction pathway in dendritic cells and granulocytes, J Exp Med 204 (2007), 2705-2718.
54. B. Molon, G. Gri, M. Bettella, C. GomezMouton, A. Lanzavecchia, A.C. Martinez et al., T cell costimulation by chemokine receptors, Nat Immunol 6 (2005), 465-471.
55. J.M. Busillo and J.L. Benovic, Regulation of CXCR4 signaling, Biochim Biophys Acta 1768 (2007), 952-963.
56. H.Y. Liu, G.B. Wen, J. Han, T. Hong, D. Zhuo, Z. Liu etal., Inhibition of gluconeogenesis in primary hepatocytes by stromal cellderived factor1 (SDF1) through a cSrc/ Aktdependent signaling pathway, J Biol Chem 283 (2008), 30642-30649.
57. M.Wysoczynski,M.Kucia, J. Ratajczak andM.Z. Ratajczak, Cleavage fragments of the third complement component (C3) enhance stromal derived factor1 (SDF1) mediated platelet production during reactive postbleeding thrombocytosis, Leukemia 21 (2007), 973-982.
58. N. Volinsky, A. Gantman and D. Yablonski, A Pakand Pixdependent branch of the SDF1alpha signalling pathway mediates T cell chemotaxis across restrictive barriers, Biochem J 397 (2006), 213-222.
59. G.M. Fuhler, A.L. Drayer, S.G. Olthof, J.J. Schuringa, P.J. Coffer and E. Vellenga, Reduced activation of protein kinase B, Rac, and Factin polymerization contributes to an impairment of stromal cell derived factor1 induced migration of CD34+ cells from patients with myelodysplasia, Blood 111 (2008), 359-368.
60. B. Tilton, L. Ho, E. Oberlin, P. Loetscher, F. Baleux, I. ClarkLewis et al., Signal transduction by CXC chemokine receptor 4. Stromal cellderived factor 1 stimulates prolonged protein kinase B and extracellular signalregulated kinase 2 activation in T lymphocytes, J ExpMed 192 (2000), 313-324.
61. A.M. Glodek, Y. Le, D.M. Dykxhoorn, S.Y. Park, G. Mostoslavsky, R. Mulligan et al., Focal adhesion kinase is required for CXCL12induced chemotactic and proadhesive responses in hematopoietic precursor cells, Leukemia 21 (2007), 1723-1732.
62. R.K. Ganju, S.A. Brubaker, J. Meyer, P. Dutt, Y. Yang, S. Qin et al., The alphachemokine, stromal cellderived factor1alpha, binds to the transmembraneGproteincoupled CXCR4 receptor and activates multiple signal transduction pathways, J Biol Chem 273 (1998), 23169-23175.
63. J.F.Wang, I.W. Park and J.E.Groopman, Stromal cellderived factor1alpha stimulates tyrosine phosphorylation ofmultiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide3 kinase and protein kinase C, Blood 95 (2000), 2505-2513.
64. Y. Le,M. Honczarenko, A.M. Glodek, D.K. Ho and L.E. Silberstein, CXC chemokine ligand 12induced focal adhesion kinase activation and segregation into membrane domains is modulated by regulator of G protein signaling 1 in proB cells, J Immunol 174 (2005), 2582-2590.
65. K.L. Pierce, R.T. Premont and R.J. Lefkowitz, Seventransmembrane receptors, Nat Rev Mol Cell Biol 3 (2002), 639-650.
66. L.M. Luttrell and R.J. Lefkowitz, The role of betaarrestins in the termination and transduction of Gproteincoupled receptor signals, J Cell Sci 115 (2002), 455-465.
67. K.A. Defea, Stop That Cell! betaArrestinDependent Chemotaxis: A Tale of Localized Actin Assembly and Receptor Desensitization, Annu Rev Physiol 69 (2007), 535-560.
68. A.M. Fong, R.T. Premont, R.M. Richardson, Y.R. Yu, R.J. Lefkowitz and D.D. Patel, Defective lymphocyte chemotaxis in betaarrestin2and GRK6deficient mice, Proc Natl Acad Sci U S A 99 (2002), 7478-7483.
69. Z.J. Cheng, J. Zhao, Y. Sun, W. Hu, Y.L. Wu, B. Cen et al., betaarrestin differentially regulates the chemokine receptor CXCR4mediated signaling and receptor internalization, and this implicates multiple interaction sites between betaarrestinand CXCR4, J Biol Chem 275 (2000), 2479-2485.
70. Y. Sun, Z. Cheng, L. Ma and G. Pei, Betaarrestin2 is critically involved in CXCR4mediated chemotaxis, and this is mediated by its enhancement of p38MAPK activation, J Biol Chem 277 (2002), 49212-49219.
71. K.M. Kim, R.R. Gainetdinov, S.A. Laporte, M.G. Caron and L.S. Barak, G proteincoupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptorfilaminbetaarrestin complex. A case of autoreceptor regulation, J Biol Chem 280 (2005), 12774-12780.
72. M.G. Scott, V. Pierotti, H. Storez, E. Lindberg, A. Thuret, O. Muntaner et al., Cooperative regulation of extracellular signalregulated kinase activation and cell shape change by filamin A and betaarrestins, Mol Cell Biol 26 (2006), 3432-3445.
73. S. JimenezBaranda, C. GomezMouton, A. Rojas, L. MartinezPrats, E. Mira, R. Ana Lacalle et al., FilaminA regulates actindependent clustering of HIV receptors, Nat Cell Biol 9 (2007), 838-846.
74. K. Balabanian, B. Lagane, S. Infantino, K.Y. Chow, J. Harriague, B. Moepps et al., The chemokine SDF1/ CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes, J Biol Chem 280 (2005), 35760-35766.
75. J.M. Burns, B.C. Summers, Y. Wang, A. Melikian, R. Berahovich, Z.Miao et al., A novel chemokine receptor for SDF1and ITAC involved in cell survival, cell adhesion, and tumor development, J Exp Med 203 (2006), 2201-2213.
76. F. Sierro, C. Biben, L. MartinezMunoz, M. Mellado, R.M. Ransohoff, M. Li et al., Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF1 receptor, CXCR7, Proc Natl Acad Sci U S A 104 (2007), 14759-14764.
77. A. Levoye, K. Balabanian, F. Baleux, F. Bachelerie and B. Lagane, CXCR7 heterodimerizes with CXCR4 and regulates CXCL12mediated G protein signaling, Blood 113 (2009), 6085-6093.
78. K.E. Luker, M. Gupta and G.D. Luker, Imaging chemokine receptor dimerization with firefly luciferase complementation, FASEB J 23 (2009), 823-834.
79. B. Boldajipour, H. Mahabaleshwar, E. Kardash, M. ReichmanFried, H. Blaser, S. Minina et al., Control of chemokineguided cell migration by ligand sequestration,Cell 132 (2008), 463-473.
80. C. DamblyChaudiere,N. Cubedo and A.Ghysen, Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1, BMC Dev Biol 7 (2007), 23.
81. U.Naumann, E. Cameroni,M. Pruenster, H.Mahabaleshwar, E. Raz, H.G. Zerwes et al., CXCR7 functions as a scavenger for CXCL12 and CXCL11, PLoS One 5 (2010), e9175.
82. M. Thelen and S. Thelen, CXCR7, CXCR4 and CXCL12: an eccentric trio? J Neuroimmunol 198 (2008), 9-13.
83. S. Rajagopal, J. Kim, S. Ahn, S. Craig, C.M. Lam, N.P. Gerard et al., Betaarrestinbut not G proteinmediated signaling by the decoy receptor CXCR7, Proc Natl Acad Sci U S A 107 (2010), 628-632.
84. B. Haribabu, R.M. Richardson, I. Fisher, S. Sozzani, S.C. Peiper, R. Horuk et al., Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization, J Biol Chem 272 (1997), 28726-28731.
85. M.J. Orsini, J.L. Parent, S.J. Mundell, J.L. Benovic and A. Marchese, Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the cterminal tail that mediate receptor internalization, J Biol Chem 274 (1999), 31076-31086.
86. N. Signoret, M.M. Rosenkilde, P.J. Klasse, T.W. Schwartz, M.H. Malim, J.A. Hoxie et al., Differential regulation of CXCR4 andCCR5 endocytosis, JCell Sci 111 (Pt 18) (1998), 2819-2830.
87. N. Signoret, J. Oldridge, A. PelchenMatthews, P.J. Klasse, T. Tran, L.F. Brass et al., Phorbol esters and SDF1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4, J Cell Biol 139 (1997), 651-664.
88. A.Marchese, C. Raiborg, F. Santini, J.H. Keen, H. Stenmark and J.L. Benovic, The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G proteincoupled receptor CXCR4, Dev Cell 5 (2003), 709-722.
89. A. Marchese and J.L. Benovic, Agonistpromoted ubiquitination of the G proteincoupled receptor CXCR4 mediates lysosomal sorting, J Biol Chem 276 (2001), 45509-45512.
90. R. Malik and A. Marchese, Arrestin2 Interacts with the ESCRTMachinery toModulate Endosomal Sorting of CXCR4, Mol Biol Cell, 21 (2010), 2529-2541.
91. N. Watson, M.E. Linder, K.M. Druey, J.H. Kehrl and K.J. Blumer, RGS family members: GTPaseactivating proteins for heterotrimeric Gprotein alphasubunits, Nature 383 (1996), 172-175.
92. J.D. Estes, T.C. Thacker, D.L. Hampton, S.A. Kell, B.F. Keele, E.A. Palenske et al., Follicular dendritic cell regulation of CXCR4mediated germinal center CD4 T cell migration, J Immunol 173 (2004), 6169-6178.
93. G.X. Shi, K. Harrison, G.L. Wilson, C. Moratz and J.H. Kehrl, RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13, J Immunol 169 (2002), 2507-2515.
94. M. Berthebaud, C. Riviere, P. Jarrier, A. Foudi, Y. Zhang, D. Compagno et al., RGS16 is a negative regulator of SDF1CXCR4 signaling in megakaryocytes, Blood 106 (2005), 2962-2968.
95. L. Tassone, L.D. Notarangelo, V. Bonomi, G. Savoldi, A. Sensi, A. Soresina et al., Clinical and genetic diagnosis of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome in 10 patients, J Allergy Clin Immunol 123 (2009), 1170-1173, 3 e1-e3.
96. J.M. Busillo, S. Armando, R. Sengupta, O. Meucci, M. Bouvier and J.L. Benovic, Sitespecific phosphorylation of CXCR4 is dynamically regulated bymultiple kinases and results in differential modulation of CXCR4 signaling, J Biol Chem 285 (2010), 7805-7817.
97. T. Kawai, U. Choi, N.L. WhitingTheobald, G.F. Linton, S. Brenner, J.M. Sechler et al., Enhanced function with decreased internalization of carboxyterminus truncated CXCR4 responsible for WHIM syndrome, Exp Hematol 33 (2005), 460-468.
98. P.J. McCormick, M. Segarra, P. Gasperini, A.V. Gulino and G. Tosato, Impaired recruitment of Grk6 and betaArrestin 2 causes delayed internalization and desensitization of a WHIM syndromeassociated CXCR4 mutant receptor, PLoS One 4 (2009), e8102.
99. B. Lagane, K.Y. Chow, K. Balabanian, A. Levoye, J. Harriague, T. Planchenault et al., CXCR4 dimerization and betaarrestinmediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome, Blood 112 (2008), 34-44.
100. K. Balabanian, A. Levoye, L. Klemm, B. Lagane, O. Hermine, J. Harriague et al., Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling, J Clin Invest 118 (2008), 1074-1084.
101. A.V. Gulino, D. Moratto, S. Sozzani, P. Cavadini, K. Otero, L. Tassone et al., Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome, Blood 104 (2004), 444-452.
102. A. Vroon, C.J. Heijnen, R. Raatgever, I.P. Touw, R.E. Ploemacher, R.T. Premont et al., GRK6 deficiency is associated with enhanced CXCR4mediated neutrophil chemotaxis in vitro and impaired responsiveness to GCSF in vivo, J Leukoc Biol 75 (2004), 698-704.
103. M.J. Lohse, Dimerization in GPCR mobility and signaling, Curr Opin Pharmacol 10 (2010), 53-58.
104. G.Milligan, Gproteincoupled receptor heterodimerization: contribution to pharmacology and function, Br J Pharmacol 158 (2009), 5-14.
105. G.J. Babcock, M. Farzan and J. Sodroski, Ligandindependent dimerization of CXCR4, a principal HIV1 coreceptor, J Biol Chem 278 (2003), 3378-3385.
106. Y.A. Berchiche, K.Y. Chow, B. Lagane, M. Leduc, Y. Percherancier, N. Fujii et al., Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and G(alpha)(i) activation, J Biol Chem 282 (2007), 5111-5115.
107. Y. Percherancier, Y.A. Berchiche, I. Slight, R. VolkmerEngert, H. Tamamura, N. Fujii et al., Bioluminescence resonance energy transfer reveals ligandinduced conformational changes in CXCR4 homoand heterodimers, J Biol Chem 280 (2005), 9895-9903.
108. S.Minina, M. ReichmanFried and E. Raz, Control of receptor internalization, signaling level, and precise arrival at the target in guided cell migration, Curr Biol 17 (2007), 1164-1172.
109. K.J. Eash, A.M. Greenbaum, P.K. Gopalan and D.C. Link, CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow, J Clin Invest 120 (2010), 2423-2431.
110. P.J. Mc Guire, C. CunninghamRundles, H. Ochs and G.A. Diaz, Oligoclonality, impaired class switch and Bcell memory responses inWHIMsyndrome, Clin Immunol 135 (2010), 412-421.
111. T. Kawai, U. Choi, L. Cardwell, S.S. DeRavin, N. Naumann, N.L. WhitingTheobald et al., WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with Cterminustruncated CXCR4, Blood 109 (2007), 78-84.
112. A.Handisurya, C. Schellenbacher, B. Reininger, F.Koszik, P. Vyhnanek, A. Heitger et al., A quadrivalent HPV vaccine induces humoral and cellular immune responses inWHIMimmunodeficiency syndrome, Vaccine 28 (2010), 4837-4841.